Download PDF
Thromb Haemost 1978; 40(01): 024-036
DOI: 10.1055/s-0038-1648631
Original Article
Schattauer GmbH Stuttgart

Meseclazone, 5-Chlorosalicylic Acid and Acetylsalicvlic Acid

Comparison of their Effects on in Vitro and ex Vivo Platelet Aggregation
William Diamantis
The Department of Pharmacology, Wallace Laboratories, Cranbury, New Jersey 08512, U.S.A.
,
William C Kohlhepp
The Department of Pharmacology, Wallace Laboratories, Cranbury, New Jersey 08512, U.S.A.
,
Barbara Haertlein
The Department of Pharmacology, Wallace Laboratories, Cranbury, New Jersey 08512, U.S.A.
,
John Melton
The Department of Pharmacology, Wallace Laboratories, Cranbury, New Jersey 08512, U.S.A.
,
R Duane Sofia
The Department of Pharmacology, Wallace Laboratories, Cranbury, New Jersey 08512, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 18 October 1977

Accepted 07 January 1978

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Meseclazone and its major metabolite, 5-chlorosalicylic acid (5-CSA) have been shown to possess anti-inflammatory, analgesic and antipyretic activity. The comparative effects of these compounds on platelet aggregation were evaluated in vitro and ex vitro with acetylsalicylic acid (ASA). in vitro, meseclazone and ASA exhibited almost identical inhibitory potency of secondary phase ADP aggregation while 5-CSA was less effective. Moreover, collagen aggregation was inhibited by all three agents: ASA > meseclazone > 5- CSA. Thrombin-induced aggregation was inhibited to approximately the same extent by 5- CSA and ASA while meseclazone was inactive. The in vitro effects on the release-inducing aggregants were confirmed by ex vitro experiments in rats. These demonstrated that ASA and meseclazone inhibited collagen-induced aggregation 1 and 4 hr after oral administration although ASA was three to four times more active. ASA, but not meseclazone, was still effective 24 hr after administration. Bleeding times in rats 1 and 4 hr following oral administration of meseclazone and ASA were not altered. It is concluded that meseclazone and/or 5-CSA inhibit in vitro and ex vitro platelet aggregation initiated by the release reaction similar to ASA and other non-steroidal anti-inflammatory drugs.

 

  • References

  • 1 Al-Mondhiry H, Marcus AJ, Spaet TH. 1970; On the mechanism of platelet function inhibition by acetylsalicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 632
    PubMedSearch in Google Scholar
  • 2 Born GV R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927
    PubMedSearch in Google Scholar
  • 3 de Clerck F, Goossens J, Reneman R. 1976; Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats. Thrombosis Research 8: 179
    PubMedSearch in Google Scholar
  • 4 Edelson J, Douglas JF, Ludwig BJ, Schuster EB, Shahinian S. 1975; Absorption, distribution and metabolic fate of 7-chloro-2-methyl-3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]- benzoxazin-9-one in rats, dogs and humans. Journal of Pharmaceutical Sciences 64: 1316
    CrossrefPubMedSearch in Google Scholar
  • 5 Evans G, Packham MA, Nishizawa EE, Mustard JF, Murphy EA. 1968; The effect of acetylsalicylic acid on platelet function. Journal of Experimental Medicine 128: 877
    CrossrefPubMedSearch in Google Scholar
  • 6 Fenichel RL, Dougherty JA, Alburn HE. 1974; Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (WY-23,049) - Comparison with acetylsalicylic acid. Biochemical Pharmacology 23: 3273
    CrossrefPubMedSearch in Google Scholar
  • 7 Fleischman AI, Bierenbaum ML, Stier A. 1976; The effect of aspirin on in vivo platelet function in humans. Thrombosis Research 8: 191
    PubMedSearch in Google Scholar
  • 8 Hornstra G, ten Hoor F. 1975; The filtragometer: A new device for measuring platelet aggregation in venous blood of man. Thrombosis et Diathesis Haemorrhagica 34: 531
    PubMedSearch in Google Scholar
  • 9 Macintyre DE, Gordon JL. 1975; Duration of aspirin’s effect on human platelet aggregation. Journal of Pharmacy and Pharmacology 27: 19 P
    PubMedSearch in Google Scholar
  • 10 Macmillan DC. 1966; Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline. Nature 211: 140
    CrossrefPubMedSearch in Google Scholar
  • 11 Macmillan DC, Sim AK. 1970; A comparative study of platelet aggregation in man and laboratory animals. Thrombosis et Diathesis Haemorrhagica 24: 385
    PubMedSearch in Google Scholar
  • 12 Minsker DH, Humes JL, Jordan PT, Kling PJ, Wolf GL. 1977. Prostaglandin synthetase inhibitors as antithrombotic agents. In: Silver MJ, Smith JB, Kocsis JJ. (eds) Prostaglandins in Hematology. Spectrum Publications; New York: p 331
    Search in Google Scholar
  • 13 Minsker DH, Jordan PT, Macmillan A. 1974. Inhibition of platelet aggregation by cyproheptadine. In: Sherry S, Scriabine A. (eds) Platelets and Thrombosis. University Park Press; Baltimore: p 161
    Search in Google Scholar
  • 14 Mustard JF, Packham MA. 1970; Factors influencing platelet function: Adhesion, release and aggregation. Pharmacological Reviews 22: 97
    PubMedSearch in Google Scholar
  • 15 Mustard JF, Packham MA. 1975; Platelets, thrombosis and drugs. Drugs 9: 19
    CrossrefPubMedSearch in Google Scholar
  • 16 Nishizawa EE, Wynalda DJ, Suydam DE, Molony BA. 1973; Flurbiprofen, a new potent inhibitor of platelet aggregation. Thrombosis Research 3: 577
    CrossrefPubMedSearch in Google Scholar
  • 17 O’Brien JR. 1968; Effects of salicylates on human platelets. Lancet 1: 779
    PubMedSearch in Google Scholar
  • 18 Okumura T, Jamieson GA. 1976; Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetin. Thrombosis Research 8: 701
    CrossrefPubMedSearch in Google Scholar
  • 19 Packham MA, Kinlough-Rathbone RL, Reimers HJ, Scott S, Mustard JF. 1977. Mechanisms of platelet aggregation independent of adenosine diphosphate. In: Silver MJ, Smith JB, Kocsis JJ. (eds) Prostaglandins in Hematology. Spectrum Publications; New York: P 247
    Search in Google Scholar
  • 20 Packham MA, Mustard JF. 1969; The effect of pyrazole compounds on thrombin-induced platelet aggregation. Proceedings of the Society for Experimental Biology and Medicine 130: 72
    PubMedSearch in Google Scholar
  • 21 Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyl AF, Hirsh J, Packham MA, Mustard JF. 1976; In vitro and in vivo functions of thrombin-treated platelets. Thrombosis and Haemostasis 35: 151
    Thieme ConnectPubMedSearch in Google Scholar
  • 22 Renaud P, Godu J. 1970; Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats. Canadian Medical Association Journal 103: 1037
    PubMedSearch in Google Scholar
  • 23 Rosenberg FJ, Gimber-Phillips PE, Groblewski GE, Davison C, Phillips DK, Goralnick SJ, Cahill ED. 1971; Acetylsalicylic acid: Inhibition of platelet aggregation in the rabbit. Journal of Pharmacology and Experimental Therapeutics 779: 410
    PubMedSearch in Google Scholar
  • 24 Roth GJ, Majerus PW. 1975; The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. Journal of Clinical Investigation 56: 624
    CrossrefPubMedSearch in Google Scholar
  • 25 Roth GJ, Stanford N, Majerus PW. 1975; Acetylation of prostaglandin synthetase by aspirin. Proceedings of the National Academy of Sciences (USA) 72: 3073
    CrossrefPubMedSearch in Google Scholar
  • 26 Snedecor GW, Cochran WG. 1967. Statistical Methods. 6. Iowa State University Press; Ames, Iowa: p 135
    Search in Google Scholar
  • 27 Sofia RD, Diamantis W, Gordon R, Kletzkin M, Berger FM, Edelson J, Singer H, Douglas JF. 1974; Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-2- methyl-3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]-benzoxazin-9-one (W-2395). European Journal of Pharmacology 26: 51
    CrossrefPubMedSearch in Google Scholar
  • 28 Sofia RD, Diamantis W, Ludwig BJ. 1975; Comparative anti-inflammatory, analgesic and antipyretic activities of 7-chloro-2-methyl-3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]-benzoxazin- 9-one and 5-chlorosalicylic acid in rats. Journal of Pharmaceutical Sciences 64: 1321
    CrossrefPubMedSearch in Google Scholar
  • 29 Stella L, Donati MB, de Gaetano E. 1975; Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thrombosis Research 7: 709
    CrossrefPubMedSearch in Google Scholar
  • 30 Stuart RK. 1970; Platelet function studies in human beings receiving 300 mg of aspirin per day. Journal of Laboratory and Clinical Medicine 75: 463
    PubMedSearch in Google Scholar
  • 31 Weiss HJ, Aledort LM, Kochwa S. 1968; The effect of salicylates on the hemostatic properties of platelets in man. Journal of Clinical Investigation 47: 2169
    CrossrefPubMedSearch in Google Scholar